A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,013 shares of ARWR stock, worth $216,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,013
Previous 12,751 21.47%
Holding current value
$216,581
Previous $331,000 41.69%
% of portfolio
0.0%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$19.36 - $29.54 $53,007 - $80,880
-2,738 Reduced 21.47%
10,013 $193,000
Q2 2024

Aug 12, 2024

BUY
$21.87 - $28.24 $52,597 - $67,917
2,405 Added 23.25%
12,751 $331,000
Q1 2024

May 09, 2024

BUY
$27.21 - $39.48 $7,101 - $10,304
261 Added 2.59%
10,346 $295,000
Q4 2023

Feb 07, 2024

BUY
$21.2 - $31.03 $213,802 - $312,937
10,085 New
10,085 $308,000
Q2 2023

Jul 28, 2023

BUY
$25.16 - $41.38 $196,147 - $322,598
7,796 New
7,796 $278,000
Q4 2022

Feb 10, 2023

BUY
$28.0 - $40.56 $141,092 - $204,381
5,039 New
5,039 $204,000
Q2 2022

Aug 09, 2022

SELL
$27.79 - $50.61 $325,754 - $593,250
-11,722 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$39.62 - $69.97 $23,336 - $41,212
589 Added 5.29%
11,722 $539,000
Q4 2021

Feb 23, 2022

BUY
$58.09 - $82.51 $646,715 - $918,583
11,133 New
11,133 $738,000
Q3 2021

Nov 09, 2021

SELL
$58.38 - $84.96 $378,594 - $550,965
-6,485 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$62.15 - $90.32 $403,042 - $585,725
6,485 New
6,485 $537,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.29B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.